Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
16.75
-0.19 (-1.12%)
Nov 21, 2024, 11:44 AM EST - Market open

Cartesian Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21
Market Capitalization
426107--
Enterprise Value
226123--
Last Close Price
16.9420.68--
PS Ratio
4.334.11--
PB Ratio
512.19-0.77--
EV/Sales Ratio
4.714.75--
Debt / Equity Ratio
19.48-0.080.400.18
Debt / EBITDA Ratio
--2.01-
Asset Turnover
0.210.111.26-
Quick Ratio
10.511.265.766.38
Current Ratio
10.701.335.916.42
Return on Equity (ROE)
-7029.26%-70.21%-
Return on Assets (ROA)
-10.95%-19.75%10.35%-
Return on Capital (ROIC)
-224.77%-3022.09%12.98%-
Earnings Yield
-65.59%-205.34%--
FCF Yield
-11.24%-48.01%--
Buyback Yield / Dilution
-6.33%-27.59%-
Total Shareholder Return
-6.33%-27.59%-
Source: S&P Capital IQ. Standard template. Financial Sources.